Open AccessSurvival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma
Author(s) -
Irini Youssef,
Virginia Osborn,
Anna Lee,
Evangelia Katsoulakis,
Ami Kavi,
Kwang Nam Choi,
Joseph Safdieh,
David Schreiber
Publication year - 2019
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo.2019.02.06
Subject(s) - medicine , stage (stratigraphy) , basal cell , oncology , overall survival , paleontology , biology
Standard of care treatment for anal squamous cell carcinoma (SCC) is concurrent chemoradiation (CRT). However, the necessity of CRT over radiation alone for T1-2N0 disease is less certain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom